Discover how blood stem cells release IL-10 to regulate inflammation and protect bone marrow, offering new therapeutic ...

Researchers sought to determine whether using HRD sources for HSCT would be effective for pediatric patients with hematologic cancers compared with UCB sources.

A novel regimen significantly reduced risk for moderate to severe chronic graft-versus-host disease for certain patients who ...

A senior undergraduate from Shanghai-based East China University of Science and Technology completed a donation of ...

Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival.

Adia Nutrition (OTC Pink: ADIA), a trailblazer in advanced healthcare solutions, is excited to announce that its subsidiary, ...

Our blood consists of many cell types that develop through different stages from a precursor type -- the blood stem cell. An international research team has now investigated the developmental pathways ...

Antibiotic nonsusceptibility and MDR-E infections were consistently more prevalent among adult HSCT recipients than in those with no history of HSCT.

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...